Abdi Monireh, Rezaei Elham, Mirghafourvand Mojgan, Ebrahimi Fatemeh, Payahoo Laleh, Shafiei-Kandjani Alireza, Ghanbari-Homaie Solmaz
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran.
Heliyon. 2025 Jan 20;11(2):e42096. doi: 10.1016/j.heliyon.2025.e42096. eCollection 2025 Jan 30.
Postpartum depression is a multifactorial and complex disorder. Various approaches for preventing and treating this condition have been suggested. Nevertheless, there is no definitive proof confirming their efficacy. This study is designed to assess the effectiveness of basil in preventing postpartum depression (primary outcome) and sleep quality (secondary outcome).
This triple-blind parallel clinical trial (participants, the researcher, and the data analyst were blinded to the assigned interventions) included 78 postpartum women at Taleghani Hospital, Tabriz, Iran, between April 2023 and April 2024. Participants who scored 12 or less on the Edinburgh Postnatal Depression Scale (EPDS) were included in the study. The intervention started within 72 h following birth and continued for eight weeks postpartum. The intervention group received two daily capsules containing dried basil leaf powder, while the control group received 500 mg of starch. The EPDS and postpartum sleep quality scale were completed through structured interviews at eight weeks postpartum. The Mann-Whitney test was used to compare the mean postpartum depression scores before and after the intervention, and ANCOVA was used to compare the mean postpartum sleep quality scores.
The median (25th, 75th percentile) depression score after intervention in the basil and placebo groups was 1.0 (0.0, 2.0) and 1.0 (0.0, 3.0), respectively, with no statistically significant difference between the groups (p = 0.966). The mean (standard deviation) sleep quality score after the intervention in the basil and placebo groups was 17.63 (3.44) and 16.15 (3.20), respectively. There was no statistically significant difference in sleep quality scores between the basil and placebo groups (p = 0.400).
The results show that basil does not prevent postpartum depression or improve sleep quality. Future studies should investigate the effects of basil at higher doses and in extract form.
产后抑郁症是一种多因素的复杂疾病。已经提出了各种预防和治疗这种疾病的方法。然而,没有确凿的证据证实它们的有效性。本研究旨在评估罗勒在预防产后抑郁症(主要结局)和睡眠质量(次要结局)方面的有效性。
这项三盲平行临床试验(参与者、研究人员和数据分析人员对分配的干预措施不知情)纳入了2023年4月至2024年4月期间在伊朗大不里士塔莱加尼医院的78名产后妇女。在爱丁堡产后抑郁量表(EPDS)上得分12分及以下的参与者被纳入研究。干预在产后72小时内开始,并持续到产后八周。干预组每天服用两粒含有干罗勒叶粉末的胶囊,而对照组服用500毫克淀粉。产后八周通过结构化访谈完成EPDS和产后睡眠质量量表。使用曼-惠特尼检验比较干预前后的产后抑郁平均得分,并使用协方差分析比较产后睡眠质量平均得分。
罗勒组和安慰剂组干预后的抑郁评分中位数(第25百分位数,第75百分位数)分别为1.0(0.0,2.0)和1.0(0.0,3.0),两组之间无统计学显著差异(p = 0.966)。罗勒组和安慰剂组干预后的睡眠质量平均得分(标准差)分别为17.63(3.44)和16.15(3.20)。罗勒组和安慰剂组的睡眠质量得分无统计学显著差异(p = 0.400)。
结果表明,罗勒不能预防产后抑郁症或改善睡眠质量。未来的研究应调查更高剂量和提取物形式的罗勒的效果。